Aemetis (NASDAQ: AMTX) is one of 25 publicly-traded companies in the “Industrial organic chemicals” industry, but how does it compare to its peers? We will compare Aemetis to similar companies based on the strength of its institutional ownership, profitability, dividends, analyst recommendations, valuation, earnings and risk.
Insider & Institutional Ownership
15.9% of Aemetis shares are held by institutional investors. Comparatively, 52.8% of shares of all “Industrial organic chemicals” companies are held by institutional investors. 24.2% of Aemetis shares are held by insiders. Comparatively, 14.0% of shares of all “Industrial organic chemicals” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
This table compares Aemetis and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current ratings and recommmendations for Aemetis and its peers, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Aemetis presently has a consensus price target of $2.00, suggesting a potential upside of 11.11%. As a group, “Industrial organic chemicals” companies have a potential upside of 9.80%. Given Aemetis’ higher probable upside, analysts plainly believe Aemetis is more favorable than its peers.
Volatility & Risk
Aemetis has a beta of -0.67, meaning that its stock price is 167% less volatile than the S&P 500. Comparatively, Aemetis’ peers have a beta of 0.50, meaning that their average stock price is 50% less volatile than the S&P 500.
Valuation and Earnings
This table compares Aemetis and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Aemetis||$150.15 million||-$30.30 million||-2.02|
|Aemetis Competitors||$3.36 billion||$346.13 million||4.23|
Aemetis’ peers have higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Aemetis peers beat Aemetis on 9 of the 12 factors compared.
Aemetis Company Profile
Aemetis, Inc. operates as an international renewable fuels and bio-chemicals company in North America and India. It focuses on the production of advanced fuels and chemicals through the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into advanced bio refineries. The company owns and operates a biodiesel plant in Kakinada, India; and an ethanol plant in Keyes, California. Aemetis, Inc. sells biodiesel and glycerin to resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.